European Journal of Haematology: Vol 94, No 4

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

European Journal of Haematology

Journal list menu

Tools

Follow journal

European Journal of Haematology: Volume 94, Issue 4

Editorial

Switching haemophilia products and inhibitor risk: a United States' perspective

Review Articles

Switching treatments in haemophilia: is there a risk of inhibitor development?

Role of allogeneic stem cell transplantation in mantle cell lymphoma

Original Articles

Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma

Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

HAUSP compartmentalization in chronic myeloid leukemia

Co-inheritance of the rare β hemoglobin variants Hb Yaounde, Hb Görwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling

LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens

Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network

The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma

TP53 mutations and MDM2^SNP309 identify subgroups of AML patients with impaired outcome

Case Reports

Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome

Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura

Clinical Pictures

Double-hit lymphoma mimicking acute lymphoblastic leukemia at presentation

Tools

More from this journal

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

European Journal of Haematology

Journal list menu

Tools

Follow journal

European Journal of Haematology: Volume 94, Issue 4

Download PDFs

Editorial

Switching haemophilia products and inhibitor risk: a United States' perspective

Review Articles

Switching treatments in haemophilia: is there a risk of inhibitor development?

Role of allogeneic stem cell transplantation in mantle cell lymphoma

Original Articles

Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma

Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

HAUSP compartmentalization in chronic myeloid leukemia

Co-inheritance of the rare β hemoglobin variants Hb Yaounde, Hb Görwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling

LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens

Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network

The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma

TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

Case Reports

Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome

Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura

Clinical Pictures

Double-hit lymphoma mimicking acute lymphoblastic leukemia at presentation

Sign up for email alerts

Tools

More from this journal

TP53 mutations and MDM2^SNP309 identify subgroups of AML patients with impaired outcome